Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

In this article, I explore two reasons why investors have a short-term bearish view against CGC. The two reasons are: 1) CGC shares will continue to dilute as they explore investment opportunities and 2) CGC will likely not meet their EBTIDA target for 2022.

Why Canopy Growth At $18 Is A Great Investment Opportunity

Phil Shaer is stepping down from his role as chief legal officer at the Canadian cannabis giant Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC), Marijuana Busines Daily reported Monday. According to a regulatory filing with the U.S. Securities and Exchange Commission, Shaer recently notified the company he would resign, effective October 1.

Canopy Growth's Exec Phil Shaer Steps Down As Head Of Legal Department

Aurora Cannabis

Cronos Group

Tilray Brands

Cann Gr (OTC:CNGGF) shares closed up 5.84% at $0.21 with an estimated market cap of $66.8M. Cansortium (OTC:CNTMF) shares closed up 4.75% at $0.64 with an estimated market cap of $141.3M.

Bearish Wave Tumbles Marijuana Stocks

Marijuana earnings reports start arriving tomorrow, but Wall Street isn't optimistic.

Why Aurora Cannabis, Canopy Growth, and Tilray Stock Tumbled Today

After Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) revealed that its cannabis sales of CA$136 million ($108 million) did not reach a consensus of CA$151 million in the first three months of fiscal 2022, Cantor Fitzgerald's Pablo Zuanic placed a 12-month price target of CA$30.5 ($24.3) against a price of CA$18.9 in August. At that time, the analyst was concerned about the "the lack of profit margin and cash flow improvement" the company's earnings report revealed.

Canopy Growth's Stock Dips After Analyst Cuts Price On Lower Sales, Confesses Preference For Tilray

The U.S.-listed shares of Canopy Growth Corp (NASDAQ:CGC) are down 4.8% to trade at $14.01 this morning, weighed down by a price-target cut from Cantor Fitzgerald.

Analyst Cuts Canopy Growth Stock Price Target on Dismal Outlook

Canopy Growth Corp. WEED, -0.48% CGC, -0.81% analyst Pablo Zuanic on Monday cut his 12-month price target on Canopy Growth Corp. c:weed, CGC, -0.81% to C$21 from C$30.50 on a lower sales outlook for the Canadian cannabis company amid price pressure in the business. Zuanic reiterated a neutral rating on the stock and said he expects September quarterly sales to fall to C$135 million, compared to the analyst consensus of C$156 million.

Cantor Fitzgerald cuts Canopy Growth price target on lower sales

Flora Growth Corp

GrowGeneration Corp

HEXO Corp

High Tide

InMed Pharmaceuticals

Akerna Corp

SNDL Inc.

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

9 Cannabis Stocks Lighting Up The News Cycle

Amplify Alternative Harvest ETF

The pot investment theme came out of the gate hot. But it crashed hard and hasn't found footing yet.

3 Cannabis Stocks to Buy Despite the Selloff

Image via Canopy Growth As a global leader in diversified medical cannabis, hemp and devices, Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED) has been disrupting the world of cannabinoids since 2013. Today, the company launches whisl — a fresh brand in CBD and a new vape designed to manage mood throughout the day.

Change Your Mood with a Quick Hit: Canopy Growth Launches whisl, First-Ever CBD Vape

Canopy Growth Corporation (CGC) 2021 Annual General and Special Meeting of Shareholders (Transcript)

Cannabis stocks like Canopy Growth Corp. are stuck in a bearish vortex. Traders should avoid buying shares of CGC stock for now.

Canopy Growth Is Getting Dismantled Day-by-Day

Canadian cannabis giant Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) is launching its first-ever CBD vape, dubbed 'whisl.' Designed to deliver the wellness effects of CBD throughout the day and night, the nicotine-free CBD vaporizer is poised to help consumers "dial in to their desired effect – focus, calm, or winding down," the Smiths Falls-based company said Tuesday.

Canopy Growth's Stock Slightly Up On Announcing Launch Of Its First-Ever CBD Vape 'Whisl'

New CBD vape with interchangeable pod system available today on ShopCanopy.com and through exclusive nationwide retail partnership with Circle K, beginning October 1 SMITHS FALLS, ON and NEW YORK, Sept. 14, 2021 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) ("Canopy Growth" or "the Company"), a world-leading diversified cannabis, hemp, and vaporization company, today announced the launch of the company's first-ever CBD vape, whisl.

Introducing whisl, an Innovative CBD Vape Designed to Manage Your Mood Throughout the Day

While the public may want cannabis legalization, getting the pivotal piece of legalization will be a roadblock for CGC stock. The post Washington Acrimony Hurts the Case for Canopy Growth appeared first on InvestorPlace.

Washington Acrimony Hurts the Case for Canopy Growth

OrganiGram Holdings Inc.

Could These Canadian Marijuana Stocks Deliver Short Term Gains In September? The post Canadian Marijuana Stocks In September 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks In September 2021

The Canadian pot company's first-quarter earnings gave a mixed message.

Is All Hope Lost for Canopy Growth After Q1 Earnings?

Applied DNA Sciences

Lexaria Bioscience

5 Cannabis Stocks That Lit Up Wall Street This Week

Highly anticipated vape line-up features brand's signature sleek designs and superior craftsmanship TUTTLINGEN, Germany, Sept. 9, 2021 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), a subsidiary of world-leading diversified cannabis, hemp, and vaporization company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today announced the release of three new vaporizer updates: the limited edition VOLCANO ONYX, the enhanced CRAFTY+, and the first-ever MIGHTY+.

STORZ & BICKEL Unveils New Limited Edition VOLCANO ONYX, Enhanced CRAFTY+ and First-Ever MIGHTY+

Canopy Growth's (CGC) CEO David Klein Presents at 2021 Barclays Global Consumer Staples Conference Transcript

Cipher Pharms Inc (OTC:CPHRF) shares closed up 11.91% at $1.89 with an estimated market cap of $50.1M. Body and Mind (OTC:BMMJ) shares closed up 8.82% at $0.5 with an estimated market cap of $54.1M.

Bearish Wave Smokes Up Marijuana Stocks - Canopy Growth And Hexo Among Top Losers For Today

CNN sounds the alarm on marijuana's risks to heart health.

Why Aurora Cannabis, Canopy Growth, Hexo, and Sundial Growers Stocks All Tumbled Today

Canada-based cannabis producer Lotus Ventures Inc. (CSE:J) (OTC:LTTSF) (FRA: LV9) has received its Standard Processing license. This means the company is now authorized to possess, produce and sell cannabis directly to provincial distributors in Canada.

Lotus Ventures Receives License To Produce, Sell, Distribute Cannabis To Provincial Canadian Distributors

Which Canadian Cannabis Company Is In the Best Position to Enter the U.S. Market?

News for Canopy Growth Stock (CGC)